• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Energy

Cramer: There Should Be More Takeovers Where These Came From

Buying's good for the acquirers, which should give other companies ideas.
By JIM CRAMER Aug 30, 2017 | 02:47 PM EDT
Stocks quotes in this article: GILD, KITE, CELG, BLUE, UTX, COL, JNJ, INCY, TECD, AVT, NEFF, URI

The takeovers are coming, the takeovers are coming.

My colleague David Faber reported that this morning on Squawk on the Street. Now I am analyzing it because of the movement in stocks, which shows that buying's good news for the acquirers, which is often the key for the next wave of acquisitions.

Let's start with Gilead (GILD) . Here's a company with a stock that has done nothing because the drug that Gilead has developed to fight hepatitis C is too good: It cures the illness. That makes it a cash cow but a short-lived one given that eventually everyone will be cured by the drug.

For years, people have waited for Gilead to put that money to work. I have endlessly described the stock as dead money until it does something.

Sure enough, on Monday it shelled out $12 billion for the loss-making Kite Pharma (KITE) , betting that its CAR-T formulations will get FDA approval to attack blood cancers, among other illnesses.

Gilead's stock has vaulted almost the equivalent of how much it spent to buy Kite, even as there is little hope Kite can be accretive for three years.

This purchase has started the chatter that Celgene (CELG) will buy Bluebird Bio (BLUE) , which is working on some promising gene therapies. As with Gilead-Kite, both Celgene and Blue Bird have been moving up. It's a virtuous circle.

Then there's the ongoing saga of when United Technologies (UTX) will buy Rockwell Collins (COL) . We have been behind both companies because they are part of one of the greatest bull markets of the era, the endless need for more planes because of the middle-classification of the world and the flush nature of many airlines, especially in the U.S. United Technologies' stock has been on a tear, as has Rockwell Collins'. There's the virtuous circle again.

My take? These moves make sense. Take a look at how well the stock of Johnson & Johnson (JNJ) has done ever since it bought Actelion for $30 billion in cash back in January. It's gained about 16 points off a $115 basis.

I think these moves are behind the action today in frequent takeover candidate Incyte (INCY) , another biotech company with cancer formulations.

It's not just aerospace and drugs. The stock of Tech Data's (TECD) been on the move ever since it bought Avnet's (AVT) service business for $2.6 billion in September 2016. That deal helped move Tech Data's stock from $69 to $108. The thought is that Tech Data's stock will move even higher when it reports tomorrow.

Finally there's the purchase of Neff (NEFF) by United Rentals (URI) for $1.3 billion earlier this month. Maybe this deal comes under the category that it is better to be lucky than good, but Neff, a very solid equipment rental company, has heavy exposure to the Southeast, exactly where capacity is needed to help clean up the monumental flooding in Houston. This stock's been on a jet propulsion ride ever since Houston's flooding began, and I think the move is far from over.

I think all these stocks demonstrate one salient fact: If the acquirers' stocks move up, then there will be a ton of acquisitions soon. There had been a sense that perhaps businesses should wait to buy because of something that could come out of the Trump administration that could influence tax policies and acquisitions. I think corporate America has given up on dysfunctional government and is now going full speed ahead on acquisitions. Ripe areas? Drugs, aerospace and even oils, if the price of oil were to drop to the low $40s. All bad news for the shorts and good news for the longs. 

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, has no positions in the stocks mentioned.

TAGS: Investing | U.S. Equity | Transportation | Healthcare | Energy | Technology | Markets | Mergers and Acquisitions | Stocks

More from Energy

Here's How Investors Can Get in on Soaring Uranium Prices

Bruce Kamich
Jun 1, 2023 12:33 PM EDT

The charts of this fund are giving off a positive glow.

It's a Long Shot, but Here's My Ideal Scenario to Keep the Fed in Check

Bob Byrne
May 30, 2023 7:15 AM EDT

It involves people pocketing their savings from lower gasoline prices so that the economy cools and the Fed doesn't need to raise rates again.

3 High-Yield International Oil & Gas Majors

Bob Ciura
May 27, 2023 7:15 AM EDT

The top global energy names are returning more cash to shareholders through dividends and share repurchases.

CorEnergy Takes Important Step in Deleveraging

Jim Collins
May 25, 2023 1:15 PM EDT

However, the preferreds are no longer 'money good.' So a completely new 'distressed company' calculus has taken over.

Chevron: Drilling Down on the Charts

Bruce Kamich
May 23, 2023 2:18 PM EDT

Here's where aggressive traders could probe.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login